$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
Detailed description of tovorafenib’s indications, main types of diseases treated, and patient usage guidelines
2026-02-01 22:25:32
Check Details
Analysis of the efficacy and role of Zongatinib (Zongatinib) and its clinical efficacy in patients with different indications
2026-02-01 22:25:32
Check Details
How much does each drug of vosoritide cost, as well as purchase channels and patient cost reference instructions
2026-02-01 22:25:32
Check Details
Summary of side effects and hazards of Methylcobalamin Injection (Rozebalamin) and key points of safe medication guidance
2026-02-01 22:25:32
Check Details
Which generation of targeted drugs does cobimetinib belong to? Which tumor patients are suitable for use?
2026-02-01 22:25:32
Check Details
Detailed explanation of the efficacy and side effects of macitentan (Aoposu), and a summary of real patient feedback
2026-02-01 22:25:32
Check Details
Is it safe to take Tilorisen (Harcos) for half a year to maintain normal liver function? Summary of expert advice
2026-02-01 22:25:32
Check Details
Elotuzumab production country background
2026-02-01 22:25:32
Check Details
Injection methods and usage guidelines for bimekizumab
2026-02-01 22:25:32
Check Details
The latest updates on ensifentrine-Ohtuvayre’s domestic application for marketing in 2026
2026-02-01 22:25:32
Check Details
Efficacy and mechanism of action of pyrotinib/arini
2026-02-01 22:25:32
Check Details
Introduction to the injection methods and related precautions of Fulvestrant/Fuxit
2026-02-01 22:25:32
Check Details
1
2
...
2399
2400
2401
2402
2403
2404
2405
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma